Covered recipient · General Payments record
ELAINE I KINDER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021
$269.18
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $269.18 | 18 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $189.95 | 13 |
| Neurocrine BioSciences, Inc. | $36.43 | 2 |
| Amgen Inc. | $24.54 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.26 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $269.18 | 18 |
Payment records · PY2021 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $24.48 | 02/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674885 | CMS |
| AbbVie Inc. | $12.76 | 03/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674889 | CMS |
| AbbVie Inc. | $3.50 | 04/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674893 | CMS |
| AbbVie Inc. | $19.07 | 04/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674897 | CMS |
| AbbVie Inc. | $14.43 | 05/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674901 | CMS |
| AbbVie Inc. | $23.19 | 06/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674905 | CMS |
| AbbVie Inc. | $27.18 | 08/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674909 | CMS |
| AbbVie Inc. | $12.43 | 09/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674913 | CMS |
| AbbVie Inc. | $4.59 | 09/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674917 | CMS |
| AbbVie Inc. | $9.38 | 10/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674921 | CMS |
| AbbVie Inc. | $10.21 | 10/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674925 | CMS |
| AbbVie Inc. | $18.04 | 11/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674929 | CMS |
| AbbVie Inc. | $10.69 | 12/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794674933 | CMS |
| Amgen Inc. | $12.63 | 06/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 826482285 | CMS |
| Amgen Inc. | $11.91 | 08/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 826482287 | CMS |
| Neurocrine Biosciences, Inc. | $17.84 | 06/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 837845609 | CMS |
| Neurocrine Biosciences, Inc. | $18.59 | 07/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 837845611 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.26 | 09/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 851963961 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.